| 24.02 Data as of 3:56pm ET |  -0.27 / -1.11%Today’s Change | 18.37 Today|||52-Week Range 30.20 | -0.37% Year-to-Date |
| Previous close | 24.29 |
| Today’s open | 24.28 |
| Day’s range | 23.94 - 24.35 |
| Volume | 190,731 |
| Average volume (3 months) | 232,648 |
| Market cap | $394.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -3.36% |
| Earnings growth (next 5 years) | +90.00% |
| Revenue growth (last year) | +38.78% |
| P/E ratio | 30.4 |
| Price/Sales | 2.07 |
| Price/Book | 1.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| IMMUImmunomedics Inc | +0.16 | +3.72% |
| ARAYAccuray Inc | -0.08 | -1.44% |
| TEARTearLab Corp | -0.15 | -1.34% |
| IVCInvacare Corp | -0.41 | -2.72% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | $0.19 |
| Annual revenue (last year) | $153.5M |
| Annual profit (last year) | $11.0M |
| Net profit margin | 7.14% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael R. Davin |
Executive Vice President- Operations David Mackie |
Corporate headquarters Westford, Massachusetts |
.
